{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:25:49Z","timestamp":1767903949445,"version":"3.49.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Scientific and Technological Research Project for Colleges and Universities of Hebei Province from Education Department of Hebei Province of China","award":["QN20131051"],"award-info":[{"award-number":["QN20131051"]}]},{"name":"Scientific and Technological Research and Development Program of Handan City of Hebei Province of China","award":["1223108086-4"],"award-info":[{"award-number":["1223108086-4"]}]}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.mehy.2013.11.023","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T13:30:18Z","timestamp":1385645418000},"page":"145-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pin1, endothelial nitric oxide synthase, and amyloid-\u03b2 form a feedback signaling loop involved in the pathogenesis of Alzheimer\u2019s disease, hypertension, and cerebral amyloid angiopathy"],"prefix":"10.1016","volume":"82","author":[{"given":"Jing-Zhang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Dong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Tao","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Wen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2013.11.023_b0005","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","article-title":"Beta-amyloid, blood vessels, and brain function","volume":"40","author":"Smith","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2013.11.023_b0010","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.mehy.2009.12.023","article-title":"Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?","volume":"74","author":"Zharikov","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.mehy.2012.12.008","article-title":"Modulation of FGF receptor signaling as an intervention and potential therapy for myelin breakdown in Alzheimer\u2019s disease","volume":"80","author":"Li","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2010.08.034","article-title":"Cerebral microbleeds and vascular cognitive impairment","volume":"299","author":"Werring","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2013.11.023_b0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2012.05.052","article-title":"Cerebral microbleeds and cognition in cerebrovascular disease: an update","volume":"322","author":"Charidimou","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2013.11.023_b0030","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2013.11.023_b0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.mehy.2012.12.031","article-title":"Getting lost in Alzheimer\u2019s disease: a break in the mental frame syncing","volume":"80","author":"Serino","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/HYPERTENSIONAHA.111.189464","article-title":"Midlife blood pressure, amyloid-beta, and risk for Alzheimer disease one more reason to treat hypertension","volume":"59","author":"Elias","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2013.11.023_b0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/EDE.0b013e31823b679c","article-title":"Hypertension and Alzheimer disease is there a link?","volume":"23","author":"Steenland","year":"2012","journal-title":"Epidemiology"},{"key":"10.1016\/j.mehy.2013.11.023_b0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000336053","article-title":"Alzheimer\u2019s disease is associated with a low prevalence of hypertension","volume":"33","author":"Kuyumcu","year":"2012","journal-title":"Dement Geriatr Cogn"},{"key":"10.1016\/j.mehy.2013.11.023_b0055","first-page":"A480","article-title":"Hypertension increases the probability of Alzheimer\u2019s disease and of being cognitively impaired not demented in wadi ara villages: a door-to-door population study","volume":"72","author":"Inzelberg","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2013.11.023_b0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000264828","article-title":"Hypertension increases the probability of Alzheimer\u2019s disease and of mild cognitive impairment in an arab community in Northern Israel","volume":"34","author":"Israeli-Korn","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.mehy.2013.11.023_b0065","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00702-011-0651-4","article-title":"Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer\u2019s disease: a long-term follow up study","volume":"118","author":"Salkovic-Petrisic","year":"2011","journal-title":"J Neural Transm"},{"key":"10.1016\/j.mehy.2013.11.023_b0070","first-page":"A662","article-title":"Clinical predictors of severe cerebral amyloid angiopathy in Alzheimer\u2019s disease patients","volume":"76","author":"Ringman","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2013.11.023_b0075","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2990.2006.00732.x","article-title":"Relationships in Alzheimer\u2019s disease between the extent of A beta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen","volume":"32","author":"Tian","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.mehy.2013.11.023_b0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2010.03329.x","article-title":"The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study","volume":"18","author":"De Reuck","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.mehy.2013.11.023_b0085","doi-asserted-by":"crossref","unstructured":"Vasileyko V, Passos GF, Quiring D, et al. Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. In: DelZoppo GJ, Gorelick PB, Eisert W, editors. Innate inflammation and stroke, New York: Academy of Sciences; 2010. p. 58\u201370.","DOI":"10.1111\/j.1749-6632.2010.05786.x"},{"key":"10.1016\/j.mehy.2013.11.023_b0090","first-page":"713","article-title":"Pathological changes on vascular smooth muscle cells in the human brain of cerebral amyloid angiopathy and hypertension","volume":"39","author":"Zhang","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2013.11.023_b0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jns.2007.03.008","article-title":"Cortico-subcortical distribution of microbleeds is different between hypertension and cerebral amyloid angiopathy","volume":"258","author":"Lee","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2013.11.023_b0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.111.178962","article-title":"Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia aging study","volume":"59","author":"Shah","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2013.11.023_b0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000092958","article-title":"Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease","volume":"22","author":"Nakata-Kudo","year":"2006","journal-title":"Dement Geriatr Cogn"},{"key":"10.1016\/j.mehy.2013.11.023_b0110","first-page":"179","article-title":"Cerebral small vessel disease, cognitive impairment and vascular dementia","volume":"54","author":"Sierra","year":"2012","journal-title":"Panminerva Med"},{"key":"10.1016\/j.mehy.2013.11.023_b0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.disamonth.2009.12.007","article-title":"Hypertension and cognitive function in the elderly","volume":"56","author":"Cherubini","year":"2010","journal-title":"Dm-Dis Mon"},{"key":"10.1016\/j.mehy.2013.11.023_b0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2047-9158-1-24","article-title":"Advances in the pathogenesis of Alzheimer\u2019s disease: focusing on tau-mediated neurodegeneration","volume":"1","author":"Duan","year":"2012","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.mehy.2013.11.023_b0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2006.06.078","article-title":"Pathogenic mechanisms in Alzheimer\u2019s disease","volume":"545","author":"Pastorino","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2013.11.023_b0130","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1161\/STROKEAHA.108.533638","article-title":"Threats to the mind aging, amyloid, and hypertension","volume":"40","author":"Iadecola","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2013.11.023_b0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tibs.2011.07.001","article-title":"Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins","volume":"36","author":"Liou","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.mehy.2013.11.023_b0140","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1017\/S1462399411001906","article-title":"Peptidyl\u2013prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease","volume":"13","author":"Lee","year":"2011","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.mehy.2013.11.023_b0145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.mehy.2013.08.020","article-title":"Could Pin1 help us conquer essential hypertension at an earlier stage? A promising early-diagnostic biomarker and its therapeutic implications for the disease","volume":"81","author":"Wang","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0150","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature04543","article-title":"The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production","volume":"440","author":"Pastorino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2013.11.023_b0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1750-1326-4-28","article-title":"The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains","volume":"4","author":"Tamayev","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.mehy.2013.11.023_b0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jgo.2011.11.007","article-title":"Understanding the link between cancer and neurodegeneration","volume":"3","author":"Driver","year":"2012","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.mehy.2013.11.023_b0165","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/HYPERTENSIONAHA.111.186742","article-title":"Pin1 as a protector of vascular endothelial homeostasis","volume":"59","author":"Erol","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2013.11.023_b0170","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.111.172338","article-title":"Pin1 deficiency causes endothelial dysfunction and hypertension","volume":"58","author":"Chiasson","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2013.11.023_b0175","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/ATVBAHA.110.213181","article-title":"Pin1 prolyl isomerase regulates endothelial nitric oxide synthase","volume":"31","author":"Ruan","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.mehy.2013.11.023_b0180","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1152\/japplphysiol.00937.2005","article-title":"Endothelial influences on cerebrovascular tone","volume":"100","author":"Andresen","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.mehy.2013.11.023_b0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12017-011-8148-8","article-title":"The 894G>T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline","volume":"13","author":"Ferlazzo","year":"2011","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.mehy.2013.11.023_b0190","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1161\/CIRCRESAHA.110.233080","article-title":"Endothelial nitric oxide modulates expression and processing of amyloid precursor protein","volume":"107","author":"Austin","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2013.11.023_b0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JAD-2012-121351","article-title":"Supplementation of nitric oxide attenuates A beta PP and BACE1 protein in cerebral microcirculation of eNOS-deficient mice","volume":"33","author":"Austin","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.mehy.2013.11.023_b0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pharmthera.2011.10.004","article-title":"Age-related changes in endothelial function and blood flow regulation","volume":"133","author":"Toda","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.mehy.2013.11.023_b0205","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3233\/JAD-2012-120670","article-title":"Cerebral blood flow regulation by nitric oxide in Alzheimer\u2019s disease","volume":"32","author":"Toda","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.mehy.2013.11.023_b0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1016\/j.mehy.2013.11.023_b0215","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/cbf.2822","article-title":"Beta-amyloid decreases detectable endothelial nitric oxide synthase in human erythrocytes: a role for membrane acetylcholinesterase","volume":"30","author":"Misiti","year":"2012","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.mehy.2013.11.023_b0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.phrs.2009.09.004","article-title":"Long-term incubation with beta-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery","volume":"61","author":"Chisari","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.mehy.2013.11.023_b0225","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00004647-200012000-00005","article-title":"Exogenous A beta 1\u201340 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice","volume":"20","author":"Niwa","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.mehy.2013.11.023_b0230","doi-asserted-by":"crossref","unstructured":"Townsend KP, Obregon D, Quadros A, et al. Proinflammatory and vasoactive effects of A beta in the cerebrovasculature. In: DeLaTorre JC, Kalaria R, Nakajima K, Nagata K, editors. Alzheimer\u2019s disease: vascular etiology and pathology, New York: Academy of Sciences; 2002. p. 65\u201376.","DOI":"10.1111\/j.1749-6632.2002.tb04799.x"},{"key":"10.1016\/j.mehy.2013.11.023_b0235","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jclinpath-2013-201515","article-title":"The role of amyloid beta in the pathogenesis of Alzheimer\u2019s disease","volume":"66","author":"Gilbert","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.mehy.2013.11.023_b0240","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1212\/WNL.0b013e3182452b40","article-title":"Genetic variation at CR1 increases risk of cerebral amyloid angiopathy","volume":"78","author":"Biffi","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2013.11.023_b0245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.STR.18.2.311","article-title":"Cerebral amyloid angiopathy \u2013 a critical-review","volume":"18","author":"Vinters","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2013.11.023_b0250","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/01.STR.14.6.924","article-title":"Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes","volume":"14","author":"Vinters","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2013.11.023_b0255","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mehy.2013.11.023_b0260","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.exger.2012.08.005","article-title":"Cerebral amyloid angiopathy impact on endothelium","volume":"47","author":"Grinberg","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.mehy.2013.11.023_b0265","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1750-3639.1996.tb00799.x","article-title":"Brain parenchymal and microvascular amyloid in Alzheimer\u2019s disease","volume":"6","author":"Vinters","year":"1996","journal-title":"Brain Pathol"},{"key":"10.1016\/j.mehy.2013.11.023_b0270","first-page":"149","article-title":"Cerebral microbleeds: a review","volume":"54","author":"Loitfelder","year":"2012","journal-title":"Panminerva Med"},{"key":"10.1016\/j.mehy.2013.11.023_b0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/WCO.0b013e328341f8c0","article-title":"Brain microbleeds: more evidence, but still a clinical dilemma","volume":"24","author":"Cordonnier","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.mehy.2013.11.023_b0280","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1161\/01.STR.0000036092.23649.2E","article-title":"Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging \u2013 analysis of risk factors for multifocal signal loss lesions","volume":"33","author":"Lee","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2013.11.023_b0285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00019052-200002000-00013","article-title":"Magnetic resonance imaging of cerebral microbleeds","volume":"13","author":"Roob","year":"2000","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.mehy.2013.11.023_b0290","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/01.STR.31.11.2665","article-title":"Frequency and location of microbleeds in patients with primary intracerebral hemorrhage","volume":"31","author":"Roob","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2013.11.023_b0295","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.4238\/vol10-3gmr1160","article-title":"Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China","volume":"10","author":"Li","year":"2011","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.mehy.2013.11.023_b0300","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1523\/JNEUROSCI.0354-12.2012","article-title":"Reducing amyloid-related Alzheimer\u2019s disease pathogenesis by a small molecule targeting filamin A","volume":"32","author":"Wang","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2013.11.023_b0305","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.mehy.2013.04.029","article-title":"Focusing on the structure and the function of Pin1: new insights into the opposite effects of fever on cancers and Alzheimer\u2019s disease","volume":"81","author":"Wang","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0310","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/380544a0","article-title":"A human peptidyl\u2013prolyl isomerase essential for regulation of mitosis","volume":"380","author":"Lu","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2013.11.023_b0315","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neurobiolaging.2005.11.009","article-title":"PIN1 promoter polymorphisms are associated with Alzheimer\u2019s disease","volume":"28","author":"Segat","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2013.11.023_b0320","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neurobiolaging.2010.05.018","article-title":"A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer\u2019s disease","volume":"33","author":"Ma","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2013.11.023_b0325","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neulet.2009.07.091","article-title":"Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden","volume":"463","author":"Jeynes","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2013.11.023_b0330","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2007-11208","article-title":"Nitric oxide and nitroxidative stress in Alzheimer\u2019s disease","volume":"11","author":"Malinski","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.mehy.2013.11.023_b0335","first-page":"154","article-title":"ENOS-G894T polymorphism is a risk factor for essential hypertension in China","volume":"48","author":"Men","year":"2011","journal-title":"Indian J Biochem Biophys"},{"key":"10.1016\/j.mehy.2013.11.023_b0340","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12640-009-9066-5","article-title":"Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease","volume":"16","author":"Aliev","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/j.mehy.2013.11.023_b0345","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.mehy.2011.12.019","article-title":"Essential hypertension \u2013 is erroneous receptor output to blame?","volume":"78","author":"Ufnal","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0350","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.mehy.2012.07.003","article-title":"Can a plant-based vaccine treat hypertension?","volume":"79","author":"Rosales-Mendoza","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0355","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.mehy.2013.05.029","article-title":"Role of the glomerular-tubular imbalance with tubular predominance in the arterial hypertension pathophysiology","volume":"81","author":"Fox","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0360","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(04)15900-X","article-title":"Convergence of atherosclerosis and Alzheimer\u2019s disease: inflammation, cholesterol, and misfolded proteins","volume":"363","author":"Casserly","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2013.11.023_b0365","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/01.wnl.0000176074.09733.a8","article-title":"Atherosclerosis Risk C. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort","volume":"65","author":"Knopman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2013.11.023_b0370","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.mehy.2012.01.011","article-title":"Hypothesis: catheter-based renal sympathetic denervation should be the initial therapy for essential hypertension","volume":"78","author":"Lakhanpal","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0375","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.mehy.2012.11.036","article-title":"Aluminum may mediate Alzheimer\u2019s disease through liver toxicity, with aberrant hepatic synthesis of ceruloplasmin and ATPase7B, the resultant excess free copper causing brain oxidation, beta-amyloid aggregation and Alzheimer disease","volume":"80","author":"Brenner","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.023_b0380","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neurobiolaging.2004.02.003","article-title":"Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer\u2019s disease Pro-CAA position statement","volume":"25","author":"Nicoll","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2013.11.023_b0385","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration","volume":"28","author":"Zlokovic","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2013.11.023_b0390","doi-asserted-by":"crossref","first-page":"C819","DOI":"10.1152\/ajpcell.00366.2007","article-title":"Protein never in mitosis gene A interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells","volume":"295","author":"Liu","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.mehy.2013.11.023_b0395","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbrc.2011.09.125","article-title":"Calpastatin is regulated by protein never in mitosis gene A interacting-1 (PIN1) in endothelial cells","volume":"414","author":"Liu","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2013.11.023_b0400","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ajh.2009.119","article-title":"Effects of antihypertensive therapy on cognitive decline in Alzheimer\u2019s disease","volume":"22","author":"Duron","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mehy.2013.11.023_b0405","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","article-title":"Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo evaluation of memory study","volume":"81","author":"Yasar","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2013.11.023_b0410","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3233\/JAD-2010-091552","article-title":"Antihypertensive treatments, cognitive decline, and dementia","volume":"20","author":"Duron","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.mehy.2013.11.023_b0415","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","article-title":"Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus","volume":"8","author":"Johnson","year":"2012","journal-title":"Alzheimers Demen"},{"key":"10.1016\/j.mehy.2013.11.023_b0420","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2012.03.027","article-title":"Revival of beta-blockers in arterial hypertension","volume":"163","author":"Vitale","year":"2013","journal-title":"Int J Cardiol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713005525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713005525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T02:33:59Z","timestamp":1564886039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987713005525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0306987713005525"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.11.023","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pin1, endothelial nitric oxide synthase, and amyloid-\u03b2 form a feedback signaling loop involved in the pathogenesis of Alzheimer\u2019s disease, hypertension, and cerebral amyloid angiopathy","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2013.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}